Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Vaccines for sexually transmitted infections: past, present and future.

Fruth U, Broutet N, Deal C, Dodet B, Meheus A.

Vaccine. 2014 Mar 20;32(14):1525-6. doi: 10.1016/j.vaccine.2014.01.051. Epub 2014 Jan 28. No abstract available.

PMID:
24480028
2.

Vaccines against sexually transmitted infections: the way forward.

Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H; participants of the 2013 STI Vaccine Technical Consultation.

Vaccine. 2014 Mar 20;32(14):1630-7. doi: 10.1016/j.vaccine.2014.01.053. Epub 2014 Jan 28. No abstract available.

PMID:
24480024
3.

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

Fletcher HA, Tanner R, Wallis RS, Meyer J, Manjaly ZR, Harris S, Satti I, Silver RF, Hoft D, Kampmann B, Walker KB, Dockrell HM, Fruth U, Barker L, Brennan MJ, McShane H.

Clin Vaccine Immunol. 2013 Nov;20(11):1683-9. doi: 10.1128/CVI.00427-13. Epub 2013 Aug 28.

4.

The blueprint for vaccine research & development: walking the path for better TB vaccines.

Lienhardt C, Fruth U, Greco M.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S33-5. doi: 10.1016/S1472-9792(12)70011-2. Review.

PMID:
22441158
5.

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.

Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Review.

PMID:
20074686
7.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Hanekom WA, Dockrell HM, Ottenhoff TH, Doherty TM, Fletcher H, McShane H, Weichold FF, Hoft DF, Parida SK, Fruth UJ.

PLoS Med. 2008 Jul 1;5(7):e145. doi: 10.1371/journal.pmed.0050145. No abstract available.

8.

Development of new tuberculosis vaccines: a global perspective on regulatory issues.

Brennan MJ, Fruth U, Milstien J, Tiernan R, de Andrade Nishioka S, Chocarro L; Developing Countries Vaccine Regulatory Network and the Ad Hoc Regulatory and TB Expert Panel.

PLoS Med. 2007 Aug;4(8):e252. No abstract available.

9.

Planning to improve global health: the next decade of tuberculosis control.

Maher D, Dye C, Floyd K, Pantoja A, Lonnroth K, Reid A, Nathanson E, Pennas T, Fruth U, Cunningham J, Ignatius H, Raviglione MC, Koek I, Espinal M.

Bull World Health Organ. 2007 May;85(5):341-7.

10.

A review of vaccine research and development: tuberculosis.

Girard MP, Fruth U, Kieny MP.

Vaccine. 2005 Dec 30;23(50):5725-31. Epub 2005 Aug 8. Review.

PMID:
16153751
11.

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development.

Kamath AT, Fruth U, Brennan MJ, Dobbelaer R, Hubrechts P, Ho MM, Mayner RE, Thole J, Walker KB, Liu M, Lambert PH; AERAS Global TB Vaccine Foundation; World Health Organization.

Vaccine. 2005 May 31;23(29):3753-61. Epub 2005 Mar 24. Review.

PMID:
15893612
12.

Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003.

Corbel MJ, Fruth U, Griffiths E, Knezevic I.

Vaccine. 2004 Jul 29;22(21-22):2675-80. No abstract available.

PMID:
15309814
13.

Prospects for new TB vaccines: Stop TB Working Group on TB Vaccine Development.

Fruth U, Young D.

Int J Tuberc Lung Dis. 2004 Jan;8(1):151-5.

PMID:
14974759
14.
15.

Diagnostic assays for leprosy based on T-cell epitopes.

Dockrell HM, Brahmbhatt S, Robertson BD, Britton S, Fruth U, Gebre N, Hunegnaw M, Hussain R, Manadhar R, Murrillo L, Pessolani MC, Roche P, Salgado JL, Sampaio E, Shahid F, Thole JE, Young DB.

Lepr Rev. 2000 Dec;71 Suppl:S55-8; discussion S58-9.

PMID:
11201888
16.

A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Dockrell HM, Brahmbhatt S, Robertson BD, Britton S, Fruth U, Gebre N, Hunegnaw M, Hussain R, Manandhar R, Murillo L, Pessolani MC, Roche P, Salgado JL, Sampaio E, Shahid F, Thole JE, Young DB.

Infect Immun. 2000 Oct;68(10):5846-55.

17.
18.

Leishmania major interferes with antigen presentation by infected macrophages.

Fruth U, Solioz N, Louis JA.

J Immunol. 1993 Mar 1;150(5):1857-64.

PMID:
8436821
19.

Immunobiology of experimental leishmaniasis.

Müller I, Fruth U, Louis JA.

Med Microbiol Immunol. 1992;181(1):1-12. Review.

PMID:
1349724
20.

Regulation of mouse T cell associated serine proteinase-1 (MTSP-1) by proteinase inhibitors and sulfated polysaccharides.

Simon MM, Tran T, Fruth U, Gurwitz D, Kramer MD.

Biol Chem Hoppe Seyler. 1990 May;371 Suppl:81-7.

PMID:
1976012
21.

Protease nexin-1 complexes and inhibits T cell serine proteinase-1.

Gurwitz D, Simon MM, Fruth U, Cunningham DD.

Biochem Biophys Res Commun. 1989 May 30;161(1):300-4.

PMID:
2786418
24.

Evidence for multiple functions of T-lymphocytes associated serine proteinases.

Simon MM, Fruth U, Simon HG, Gay S, Kramer MD.

Adv Exp Med Biol. 1989;247A:609-13. No abstract available.

PMID:
2603827
25.

Human T cell specific proteinase (HuTSP) is encoded by the T cell and natural killer cell specific human Hanukah factor (HuHF) gene.

Fruth U, Eckerskorn C, Lottspeich F, Kramer MD, Prester M, Simon MM.

FEBS Lett. 1988 Sep 12;237(1-2):45-8.

26.

Induction of T cell serine proteinase 1 (TSP-1)-specific mRNA in mouse T lymphocytes.

Simon HG, Fruth U, Eckerskorn C, Lottspeich F, Kramer MD, Nerz G, Simon MM.

Eur J Immunol. 1988 Jun;18(6):855-61.

PMID:
3260181
27.

Determination of frequency of T cells expressing the T cell-specific serine proteinase 1 (TSP-1) reveals two types of L3T4+ T lymphocytes.

Fruth U, Nerz G, Prester M, Simon HG, Kramer MD, Simon MM.

Eur J Immunol. 1988 May;18(5):773-81.

PMID:
3259928
28.

Release of biologically active fragments from human plasma-fibronectin by murine T cell-specific proteinase 1 (TSP-1).

Simon MM, Prester M, Nerz G, Kramer MD, Fruth U.

Biol Chem Hoppe Seyler. 1988 May;369 Suppl:107-12.

PMID:
3060134
29.

The T cell specific serine proteinase TSP-1: biochemical characterization, genetic analysis, and functional role.

Simon HG, Fruth U, Geiger R, Kramer MD, Simon MM.

Adv Exp Med Biol. 1988;240:535-45. No abstract available.

PMID:
3266709
31.

A novel serine proteinase (HuTSP) isolated from a cloned human CD8+ cytolytic T cell line is expressed and secreted by activated CD4+ and CD8+ lymphocytes.

Fruth U, Sinigaglia F, Schlesier M, Kilgus J, Kramer MD, Simon MM.

Eur J Immunol. 1987 Nov;17(11):1625-33.

PMID:
2960546
32.

The T cell-specific serine proteinase TSP-1 is associated with cytoplasmic granules of cytolytic T lymphocytes.

Fruth U, Prester M, Golecki JR, Hengartner H, Simon HG, Kramer MD, Simon MM.

Eur J Immunol. 1987 May;17(5):613-21.

PMID:
3556195
33.

Evidence for the involvement of a T-cell-associated serine protease (TSP-1) in cell killing.

Simon MM, Fruth U, Simon HG, Kramer MD.

Ann Inst Pasteur Immunol. 1987 Mar-Apr;138(2):309-14. No abstract available.

PMID:
3300705
34.

Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase.

Simon MM, Simon HG, Fruth U, Epplen J, Müller-Hermelink HK, Kramer MD.

Immunology. 1987 Feb;60(2):219-30.

35.

Purification and characterization of a T cell specific serine proteinase (TSP-1) from cloned cytolytic T lymphocytes.

Simon MM, Hoschützky H, Fruth U, Simon HG, Kramer MD.

EMBO J. 1986 Dec 1;5(12):3267-74.

Supplemental Content

Support Center